Gritstone Asset Management’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Gritstone Asset Management’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,338	Closed	-$160K	–	204
2022 Q4	$160K	Buy	+16,338	New	+$162K	0.2%	92

Other funds holding ORIAU

JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Gritstone Asset Management's ORIAU Position: Q1 2023 in Review

Gritstone Asset Management sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q1 2023, closing a stake of 16,338 shares — an estimated $160K sold.

Gritstone Asset Management first reported a position in ORIAU in Q4 2022 and held it in 1 quarter. The position peaked at $160K in Q4 2022. 4 funds tracked by Wall St. Rank hold ORIAU as of Q1 2023.

Gritstone Asset Management reported no remaining Orion Biotech Opportunities Corp. Units position as of Q1 2023 after selling out during the quarter.
Gritstone Asset Management sold 16,338 Orion Biotech Opportunities Corp. Units shares in Q1 2023, an estimated $160K.
Gritstone Asset Management first reported a position in Orion Biotech Opportunities Corp. Units in Q4 2022 and held it in 1 quarter.
Gritstone Asset Management's Orion Biotech Opportunities Corp. Units position peaked at $160K in Q4 2022.
4 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q1 2023.

Based on Gritstone Asset Management's 13F filing for Q1 2023, filed 5 May 2023.